Affinity Asset Advisors, LLC Vera Therapeutics, Inc. Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 355,143 shares of VERA stock, worth $7.75 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
355,143
Previous 425,000
16.44%
Holding current value
$7.75 Million
Previous $18 Million
52.54%
% of portfolio
0.95%
Previous 3.21%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
64MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$124 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$104 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$72.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$64.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$63.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $590M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...